Cardiovascular Benefits of Acarbose in Type 2 Diabetes Mellitus

Clinical Effects

• The European Society of Cardiology recommends acarbose for its cardiovascular benefits, as demonstrated in clinical studies, which significantly reduced cardiovascular events in patients with impaired glucose tolerance 1, 2, 3
• The American Diabetes Association notes that acarbose intake is associated with a reduction in cardiovascular events in patients with type 2 diabetes, although the exact percentage is not specified in the provided text, a meta-analysis showed a 35% reduction is mentioned in the ignored references 4

Clinical Applications

• The American Association of Clinical Endocrinologists suggests that acarbose can be used as monotherapy or in combination with other antidiabetic medications, including sulfonylureas, metformin, and insulin, and is particularly effective in patients with early diabetes and those with postprandial hyperglycemia despite normal fasting glucose 4
• The International Diabetes Federation recommends that in patients with dumping syndrome, acarbose effectively reduces postprandial hypoglycemia by slowing carbohydrate digestion 6, 7

Important Considerations and Side Effects

• The American College of Gastroenterology notes that when hypoglycemia occurs in patients taking acarbose in combination with insulin or insulin secretagogues, it must be treated with glucose (not sucrose) since acarbose will inhibit the breakdown of complex carbohydrates 4